(Q53648038)
Statements
Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL). (English)
1 reference
Escherichia Coli
1 reference
Cecilia Sze Kwok
1 reference
Shirley Kow Kham
1 reference
Hany Ariffin
1 reference
Hai Peng Lin
1 reference
Thuan Chong Quah
1 reference
Allen Eng Yeoh
1 reference
1 September 2006
1 reference
47
1 reference
3
1 reference
299-304
1 reference
Identifiers
1 reference